nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentosan Polysulfate—FGF4—appendage—sarcoma	0.0586	0.214	CbGeAlD
Pentosan Polysulfate—FGF1—dermis—sarcoma	0.0306	0.112	CbGeAlD
Pentosan Polysulfate—FGF1—periosteum—sarcoma	0.0254	0.0926	CbGeAlD
Pentosan Polysulfate—FGF4—embryo—sarcoma	0.0195	0.0711	CbGeAlD
Pentosan Polysulfate—FGF1—cartilage tissue—sarcoma	0.0178	0.0649	CbGeAlD
Pentosan Polysulfate—FGF4—connective tissue—sarcoma	0.0167	0.0611	CbGeAlD
Pentosan Polysulfate—FGF1—appendage—sarcoma	0.0155	0.0565	CbGeAlD
Pentosan Polysulfate—FGF2—mammary gland—sarcoma	0.0101	0.037	CbGeAlD
Pentosan Polysulfate—FGF1—endothelium—sarcoma	0.00935	0.0341	CbGeAlD
Pentosan Polysulfate—FGF1—mammary gland—sarcoma	0.00754	0.0275	CbGeAlD
Pentosan Polysulfate—FGF2—myometrium—sarcoma	0.00719	0.0263	CbGeAlD
Pentosan Polysulfate—FGF2—smooth muscle tissue—sarcoma	0.00544	0.0199	CbGeAlD
Pentosan Polysulfate—FGF1—embryo—sarcoma	0.00514	0.0188	CbGeAlD
Pentosan Polysulfate—FGF2—uterus—sarcoma	0.00466	0.017	CbGeAlD
Pentosan Polysulfate—FGF1—hematopoietic system—sarcoma	0.00459	0.0168	CbGeAlD
Pentosan Polysulfate—FGF1—connective tissue—sarcoma	0.00442	0.0161	CbGeAlD
Pentosan Polysulfate—FGF2—tendon—sarcoma	0.00409	0.0149	CbGeAlD
Pentosan Polysulfate—FGF1—smooth muscle tissue—sarcoma	0.00404	0.0148	CbGeAlD
Pentosan Polysulfate—FGF1—skin of body—sarcoma	0.00399	0.0146	CbGeAlD
Pentosan Polysulfate—FGF1—cardiac atrium—sarcoma	0.00349	0.0127	CbGeAlD
Pentosan Polysulfate—FGF2—testis—sarcoma	0.00338	0.0124	CbGeAlD
Pentosan Polysulfate—FGF1—lymphoid tissue—sarcoma	0.00323	0.0118	CbGeAlD
Pentosan Polysulfate—FGF1—testis—sarcoma	0.00252	0.00919	CbGeAlD
Pentosan Polysulfate—FGF2—lymph node—sarcoma	0.00245	0.00895	CbGeAlD
Pentosan Polysulfate—FGF1—liver—sarcoma	0.00238	0.00868	CbGeAlD
Pentosan Polysulfate—FGF1—lymph node—sarcoma	0.00182	0.00666	CbGeAlD
Pentosan Polysulfate—Anaemia—Dactinomycin—sarcoma	0.000865	0.00392	CcSEcCtD
Pentosan Polysulfate—Alopecia—Vincristine—sarcoma	0.000849	0.00385	CcSEcCtD
Pentosan Polysulfate—Jaundice—Etoposide—sarcoma	0.000845	0.00383	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Etoposide—sarcoma	0.000845	0.00383	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Thiotepa—sarcoma	0.000844	0.00383	CcSEcCtD
Pentosan Polysulfate—Malaise—Dactinomycin—sarcoma	0.000844	0.00383	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Dactinomycin—sarcoma	0.000838	0.0038	CcSEcCtD
Pentosan Polysulfate—Colitis—Epirubicin—sarcoma	0.000834	0.00378	CcSEcCtD
Pentosan Polysulfate—Alopecia—Mitoxantrone—sarcoma	0.000827	0.00375	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Epirubicin—sarcoma	0.00082	0.00372	CcSEcCtD
Pentosan Polysulfate—Vaginal inflammation—Doxorubicin—sarcoma	0.000804	0.00364	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Thiotepa—sarcoma	0.000803	0.00364	CcSEcCtD
Pentosan Polysulfate—Myalgia—Thiotepa—sarcoma	0.000803	0.00364	CcSEcCtD
Pentosan Polysulfate—Myalgia—Dactinomycin—sarcoma	0.000797	0.00361	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Epirubicin—sarcoma	0.000794	0.0036	CcSEcCtD
Pentosan Polysulfate—Discomfort—Dactinomycin—sarcoma	0.000787	0.00357	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Epirubicin—sarcoma	0.000785	0.00356	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Epirubicin—sarcoma	0.000785	0.00356	CcSEcCtD
Pentosan Polysulfate—Anaemia—Vincristine—sarcoma	0.000773	0.0035	CcSEcCtD
Pentosan Polysulfate—Colitis—Doxorubicin—sarcoma	0.000772	0.0035	CcSEcCtD
Pentosan Polysulfate—Agitation—Vincristine—sarcoma	0.000769	0.00348	CcSEcCtD
Pentosan Polysulfate—Infection—Thiotepa—sarcoma	0.000765	0.00347	CcSEcCtD
Pentosan Polysulfate—Oedema—Dactinomycin—sarcoma	0.000764	0.00346	CcSEcCtD
Pentosan Polysulfate—Infection—Dactinomycin—sarcoma	0.000759	0.00344	CcSEcCtD
Pentosan Polysulfate—Vaginal infection—Doxorubicin—sarcoma	0.000759	0.00344	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Mitoxantrone—sarcoma	0.000756	0.00342	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Thiotepa—sarcoma	0.000754	0.00342	CcSEcCtD
Pentosan Polysulfate—Anaemia—Mitoxantrone—sarcoma	0.000753	0.00341	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Vincristine—sarcoma	0.000749	0.00339	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Dactinomycin—sarcoma	0.000748	0.00339	CcSEcCtD
Pentosan Polysulfate—Malaise—Mitoxantrone—sarcoma	0.000735	0.00333	CcSEcCtD
Pentosan Polysulfate—Oesophagitis—Doxorubicin—sarcoma	0.000735	0.00333	CcSEcCtD
Pentosan Polysulfate—Anorexia—Thiotepa—sarcoma	0.000734	0.00332	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Mitoxantrone—sarcoma	0.000729	0.0033	CcSEcCtD
Pentosan Polysulfate—Anorexia—Dactinomycin—sarcoma	0.000728	0.0033	CcSEcCtD
Pentosan Polysulfate—Ecchymosis—Doxorubicin—sarcoma	0.000727	0.00329	CcSEcCtD
Pentosan Polysulfate—Mouth ulceration—Doxorubicin—sarcoma	0.000727	0.00329	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Epirubicin—sarcoma	0.000718	0.00325	CcSEcCtD
Pentosan Polysulfate—Myalgia—Vincristine—sarcoma	0.000712	0.00323	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000701	0.00318	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000696	0.00315	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Mitoxantrone—sarcoma	0.000693	0.00314	CcSEcCtD
Pentosan Polysulfate—Myalgia—Mitoxantrone—sarcoma	0.000693	0.00314	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Thiotepa—sarcoma	0.000691	0.00313	CcSEcCtD
Pentosan Polysulfate—Alopecia—Etoposide—sarcoma	0.000688	0.00312	CcSEcCtD
Pentosan Polysulfate—Discomfort—Mitoxantrone—sarcoma	0.000685	0.0031	CcSEcCtD
Pentosan Polysulfate—Oedema—Vincristine—sarcoma	0.000683	0.00309	CcSEcCtD
Pentosan Polysulfate—Infection—Vincristine—sarcoma	0.000678	0.00307	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Thiotepa—sarcoma	0.000678	0.00307	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Thiotepa—sarcoma	0.000669	0.00303	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Vincristine—sarcoma	0.000668	0.00303	CcSEcCtD
Pentosan Polysulfate—Oedema—Mitoxantrone—sarcoma	0.000665	0.00301	CcSEcCtD
Pentosan Polysulfate—Photosensitivity—Doxorubicin—sarcoma	0.000665	0.00301	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Dactinomycin—sarcoma	0.000664	0.00301	CcSEcCtD
Pentosan Polysulfate—Infection—Mitoxantrone—sarcoma	0.00066	0.00299	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Vincristine—sarcoma	0.00066	0.00299	CcSEcCtD
Pentosan Polysulfate—Constipation—Thiotepa—sarcoma	0.000658	0.00298	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Mitoxantrone—sarcoma	0.000651	0.00295	CcSEcCtD
Pentosan Polysulfate—Anorexia—Vincristine—sarcoma	0.000651	0.00295	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Mitoxantrone—sarcoma	0.000643	0.00291	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Thiotepa—sarcoma	0.000634	0.00287	CcSEcCtD
Pentosan Polysulfate—Anorexia—Mitoxantrone—sarcoma	0.000634	0.00287	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Dactinomycin—sarcoma	0.00063	0.00285	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Thiotepa—sarcoma	0.000629	0.00285	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Etoposide—sarcoma	0.000629	0.00285	CcSEcCtD
Pentosan Polysulfate—Anaemia—Etoposide—sarcoma	0.000626	0.00284	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Dactinomycin—sarcoma	0.000625	0.00283	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Vincristine—sarcoma	0.000622	0.00282	CcSEcCtD
Pentosan Polysulfate—Affect lability—Epirubicin—sarcoma	0.000621	0.00281	CcSEcCtD
Pentosan Polysulfate—Insomnia—Vincristine—sarcoma	0.000617	0.0028	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Vincristine—sarcoma	0.000613	0.00278	CcSEcCtD
Pentosan Polysulfate—Urticaria—Thiotepa—sarcoma	0.000612	0.00277	CcSEcCtD
Pentosan Polysulfate—Malaise—Etoposide—sarcoma	0.000611	0.00277	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Thiotepa—sarcoma	0.000609	0.00276	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Etoposide—sarcoma	0.000606	0.00275	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000606	0.00274	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Dactinomycin—sarcoma	0.000604	0.00274	CcSEcCtD
Pentosan Polysulfate—Mood swings—Epirubicin—sarcoma	0.000597	0.00271	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Mitoxantrone—sarcoma	0.000597	0.0027	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Vincristine—sarcoma	0.000593	0.00269	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Mitoxantrone—sarcoma	0.000593	0.00269	CcSEcCtD
Pentosan Polysulfate—Dehydration—Epirubicin—sarcoma	0.000586	0.00266	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Mitoxantrone—sarcoma	0.000585	0.00265	CcSEcCtD
Pentosan Polysulfate—Constipation—Vincristine—sarcoma	0.000584	0.00264	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Epirubicin—sarcoma	0.000582	0.00264	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Mitoxantrone—sarcoma	0.000578	0.00262	CcSEcCtD
Pentosan Polysulfate—Affect lability—Doxorubicin—sarcoma	0.000574	0.0026	CcSEcCtD
Pentosan Polysulfate—Discomfort—Etoposide—sarcoma	0.00057	0.00258	CcSEcCtD
Pentosan Polysulfate—Constipation—Mitoxantrone—sarcoma	0.000568	0.00258	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Thiotepa—sarcoma	0.000567	0.00257	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Dactinomycin—sarcoma	0.000563	0.00255	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Vincristine—sarcoma	0.000558	0.00253	CcSEcCtD
Pentosan Polysulfate—Gastritis—Epirubicin—sarcoma	0.000558	0.00253	CcSEcCtD
Pentosan Polysulfate—Mood swings—Doxorubicin—sarcoma	0.000553	0.0025	CcSEcCtD
Pentosan Polysulfate—Infection—Etoposide—sarcoma	0.000549	0.00249	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Mitoxantrone—sarcoma	0.000548	0.00248	CcSEcCtD
Pentosan Polysulfate—Pruritus—Thiotepa—sarcoma	0.000545	0.00247	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000544	0.00246	CcSEcCtD
Pentosan Polysulfate—Dehydration—Doxorubicin—sarcoma	0.000543	0.00246	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Etoposide—sarcoma	0.000541	0.00245	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Vincristine—sarcoma	0.00054	0.00245	CcSEcCtD
Pentosan Polysulfate—Liver function test abnormal—Doxorubicin—sarcoma	0.000539	0.00244	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Etoposide—sarcoma	0.000535	0.00242	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Epirubicin—sarcoma	0.000531	0.00241	CcSEcCtD
Pentosan Polysulfate—Urticaria—Mitoxantrone—sarcoma	0.000528	0.00239	CcSEcCtD
Pentosan Polysulfate—Anorexia—Etoposide—sarcoma	0.000527	0.00239	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Thiotepa—sarcoma	0.000527	0.00239	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Mitoxantrone—sarcoma	0.000526	0.00238	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Dactinomycin—sarcoma	0.000523	0.00237	CcSEcCtD
Pentosan Polysulfate—Gastritis—Doxorubicin—sarcoma	0.000516	0.00234	CcSEcCtD
Pentosan Polysulfate—Dizziness—Thiotepa—sarcoma	0.000509	0.00231	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Epirubicin—sarcoma	0.000504	0.00228	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Vincristine—sarcoma	0.000503	0.00228	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Epirubicin—sarcoma	0.000498	0.00225	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Etoposide—sarcoma	0.000497	0.00225	CcSEcCtD
Pentosan Polysulfate—Weight increased—Epirubicin—sarcoma	0.000496	0.00225	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Epirubicin—sarcoma	0.000493	0.00223	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Etoposide—sarcoma	0.000493	0.00223	CcSEcCtD
Pentosan Polysulfate—Angina pectoris—Doxorubicin—sarcoma	0.000491	0.00223	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Mitoxantrone—sarcoma	0.00049	0.00222	CcSEcCtD
Pentosan Polysulfate—Vomiting—Thiotepa—sarcoma	0.000489	0.00222	CcSEcCtD
Pentosan Polysulfate—Vomiting—Dactinomycin—sarcoma	0.000486	0.0022	CcSEcCtD
Pentosan Polysulfate—Rash—Thiotepa—sarcoma	0.000485	0.0022	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Thiotepa—sarcoma	0.000485	0.0022	CcSEcCtD
Pentosan Polysulfate—Headache—Thiotepa—sarcoma	0.000482	0.00219	CcSEcCtD
Pentosan Polysulfate—Rash—Dactinomycin—sarcoma	0.000482	0.00218	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Etoposide—sarcoma	0.000481	0.00218	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Epirubicin—sarcoma	0.000474	0.00215	CcSEcCtD
Pentosan Polysulfate—Jaundice—Epirubicin—sarcoma	0.000474	0.00215	CcSEcCtD
Pentosan Polysulfate—Constipation—Etoposide—sarcoma	0.000473	0.00214	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Epirubicin—sarcoma	0.000472	0.00214	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Vincristine—sarcoma	0.000467	0.00212	CcSEcCtD
Pentosan Polysulfate—Sweating—Epirubicin—sarcoma	0.000466	0.00211	CcSEcCtD
Pentosan Polysulfate—Pollakiuria—Doxorubicin—sarcoma	0.000466	0.00211	CcSEcCtD
Pentosan Polysulfate—Haematuria—Epirubicin—sarcoma	0.000463	0.0021	CcSEcCtD
Pentosan Polysulfate—Photosensitivity reaction—Doxorubicin—sarcoma	0.00046	0.00209	CcSEcCtD
Pentosan Polysulfate—Weight increased—Doxorubicin—sarcoma	0.000459	0.00208	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Epirubicin—sarcoma	0.000458	0.00208	CcSEcCtD
Pentosan Polysulfate—Nausea—Thiotepa—sarcoma	0.000457	0.00207	CcSEcCtD
Pentosan Polysulfate—Weight decreased—Doxorubicin—sarcoma	0.000456	0.00207	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Epirubicin—sarcoma	0.000456	0.00207	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Etoposide—sarcoma	0.000456	0.00206	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Mitoxantrone—sarcoma	0.000455	0.00206	CcSEcCtD
Pentosan Polysulfate—Nausea—Dactinomycin—sarcoma	0.000454	0.00206	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Etoposide—sarcoma	0.000452	0.00205	CcSEcCtD
Pentosan Polysulfate—Dizziness—Vincristine—sarcoma	0.000451	0.00205	CcSEcCtD
Pentosan Polysulfate—Urticaria—Etoposide—sarcoma	0.000439	0.00199	CcSEcCtD
Pentosan Polysulfate—Stomatitis—Doxorubicin—sarcoma	0.000438	0.00199	CcSEcCtD
Pentosan Polysulfate—Jaundice—Doxorubicin—sarcoma	0.000438	0.00199	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Epirubicin—sarcoma	0.000437	0.00198	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Etoposide—sarcoma	0.000437	0.00198	CcSEcCtD
Pentosan Polysulfate—Conjunctivitis—Doxorubicin—sarcoma	0.000437	0.00198	CcSEcCtD
Pentosan Polysulfate—Vomiting—Vincristine—sarcoma	0.000434	0.00197	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Epirubicin—sarcoma	0.000433	0.00196	CcSEcCtD
Pentosan Polysulfate—Sweating—Doxorubicin—sarcoma	0.000431	0.00195	CcSEcCtD
Pentosan Polysulfate—Rash—Vincristine—sarcoma	0.00043	0.00195	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Vincristine—sarcoma	0.00043	0.00195	CcSEcCtD
Pentosan Polysulfate—Haematuria—Doxorubicin—sarcoma	0.000429	0.00194	CcSEcCtD
Pentosan Polysulfate—Headache—Vincristine—sarcoma	0.000428	0.00194	CcSEcCtD
Pentosan Polysulfate—Epistaxis—Doxorubicin—sarcoma	0.000424	0.00192	CcSEcCtD
Pentosan Polysulfate—Vomiting—Mitoxantrone—sarcoma	0.000423	0.00192	CcSEcCtD
Pentosan Polysulfate—Sinusitis—Doxorubicin—sarcoma	0.000422	0.00191	CcSEcCtD
Pentosan Polysulfate—Rash—Mitoxantrone—sarcoma	0.000419	0.0019	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Mitoxantrone—sarcoma	0.000419	0.0019	CcSEcCtD
Pentosan Polysulfate—Headache—Mitoxantrone—sarcoma	0.000416	0.00189	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Etoposide—sarcoma	0.000407	0.00185	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Epirubicin—sarcoma	0.000407	0.00184	CcSEcCtD
Pentosan Polysulfate—Nausea—Vincristine—sarcoma	0.000405	0.00184	CcSEcCtD
Pentosan Polysulfate—Rhinitis—Doxorubicin—sarcoma	0.000405	0.00183	CcSEcCtD
Pentosan Polysulfate—Pharyngitis—Doxorubicin—sarcoma	0.000401	0.00182	CcSEcCtD
Pentosan Polysulfate—Nausea—Mitoxantrone—sarcoma	0.000395	0.00179	CcSEcCtD
Pentosan Polysulfate—Pruritus—Etoposide—sarcoma	0.000391	0.00177	CcSEcCtD
Pentosan Polysulfate—Alopecia—Epirubicin—sarcoma	0.000386	0.00175	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Etoposide—sarcoma	0.000378	0.00171	CcSEcCtD
Pentosan Polysulfate—Tinnitus—Doxorubicin—sarcoma	0.000376	0.00171	CcSEcCtD
Pentosan Polysulfate—Flatulence—Epirubicin—sarcoma	0.000374	0.0017	CcSEcCtD
Pentosan Polysulfate—Dizziness—Etoposide—sarcoma	0.000366	0.00166	CcSEcCtD
Pentosan Polysulfate—Alopecia—Doxorubicin—sarcoma	0.000357	0.00162	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Epirubicin—sarcoma	0.000352	0.0016	CcSEcCtD
Pentosan Polysulfate—Vomiting—Etoposide—sarcoma	0.000352	0.00159	CcSEcCtD
Pentosan Polysulfate—Anaemia—Epirubicin—sarcoma	0.000351	0.00159	CcSEcCtD
Pentosan Polysulfate—Agitation—Epirubicin—sarcoma	0.000349	0.00158	CcSEcCtD
Pentosan Polysulfate—Rash—Etoposide—sarcoma	0.000349	0.00158	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Etoposide—sarcoma	0.000348	0.00158	CcSEcCtD
Pentosan Polysulfate—Headache—Etoposide—sarcoma	0.000346	0.00157	CcSEcCtD
Pentosan Polysulfate—Flatulence—Doxorubicin—sarcoma	0.000346	0.00157	CcSEcCtD
Pentosan Polysulfate—Malaise—Epirubicin—sarcoma	0.000342	0.00155	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Epirubicin—sarcoma	0.00034	0.00154	CcSEcCtD
Pentosan Polysulfate—Nausea—Etoposide—sarcoma	0.000328	0.00149	CcSEcCtD
Pentosan Polysulfate—Ill-defined disorder—Doxorubicin—sarcoma	0.000326	0.00148	CcSEcCtD
Pentosan Polysulfate—Anaemia—Doxorubicin—sarcoma	0.000325	0.00147	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Epirubicin—sarcoma	0.000323	0.00147	CcSEcCtD
Pentosan Polysulfate—Myalgia—Epirubicin—sarcoma	0.000323	0.00147	CcSEcCtD
Pentosan Polysulfate—Agitation—Doxorubicin—sarcoma	0.000323	0.00146	CcSEcCtD
Pentosan Polysulfate—Discomfort—Epirubicin—sarcoma	0.000319	0.00145	CcSEcCtD
Pentosan Polysulfate—Malaise—Doxorubicin—sarcoma	0.000317	0.00144	CcSEcCtD
Pentosan Polysulfate—Leukopenia—Doxorubicin—sarcoma	0.000315	0.00143	CcSEcCtD
Pentosan Polysulfate—Oedema—Epirubicin—sarcoma	0.00031	0.0014	CcSEcCtD
Pentosan Polysulfate—Infection—Epirubicin—sarcoma	0.000308	0.0014	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Epirubicin—sarcoma	0.000303	0.00138	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Epirubicin—sarcoma	0.0003	0.00136	CcSEcCtD
Pentosan Polysulfate—Myalgia—Doxorubicin—sarcoma	0.000299	0.00136	CcSEcCtD
Pentosan Polysulfate—Arthralgia—Doxorubicin—sarcoma	0.000299	0.00136	CcSEcCtD
Pentosan Polysulfate—Discomfort—Doxorubicin—sarcoma	0.000296	0.00134	CcSEcCtD
Pentosan Polysulfate—Anorexia—Epirubicin—sarcoma	0.000295	0.00134	CcSEcCtD
Pentosan Polysulfate—Oedema—Doxorubicin—sarcoma	0.000287	0.0013	CcSEcCtD
Pentosan Polysulfate—Infection—Doxorubicin—sarcoma	0.000285	0.00129	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000282	0.00128	CcSEcCtD
Pentosan Polysulfate—Thrombocytopenia—Doxorubicin—sarcoma	0.000281	0.00127	CcSEcCtD
Pentosan Polysulfate—Insomnia—Epirubicin—sarcoma	0.00028	0.00127	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Epirubicin—sarcoma	0.000278	0.00126	CcSEcCtD
Pentosan Polysulfate—Hyperhidrosis—Doxorubicin—sarcoma	0.000277	0.00126	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Epirubicin—sarcoma	0.000276	0.00125	CcSEcCtD
Pentosan Polysulfate—Anorexia—Doxorubicin—sarcoma	0.000273	0.00124	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Epirubicin—sarcoma	0.000273	0.00124	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Epirubicin—sarcoma	0.000269	0.00122	CcSEcCtD
Pentosan Polysulfate—Constipation—Epirubicin—sarcoma	0.000265	0.0012	CcSEcCtD
Pentosan Polysulfate—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000261	0.00118	CcSEcCtD
Pentosan Polysulfate—Insomnia—Doxorubicin—sarcoma	0.000259	0.00118	CcSEcCtD
Pentosan Polysulfate—Paraesthesia—Doxorubicin—sarcoma	0.000258	0.00117	CcSEcCtD
Pentosan Polysulfate—Dyspnoea—Doxorubicin—sarcoma	0.000256	0.00116	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Epirubicin—sarcoma	0.000255	0.00116	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Epirubicin—sarcoma	0.000253	0.00115	CcSEcCtD
Pentosan Polysulfate—Dyspepsia—Doxorubicin—sarcoma	0.000252	0.00114	CcSEcCtD
Pentosan Polysulfate—Decreased appetite—Doxorubicin—sarcoma	0.000249	0.00113	CcSEcCtD
Pentosan Polysulfate—Urticaria—Epirubicin—sarcoma	0.000246	0.00112	CcSEcCtD
Pentosan Polysulfate—Constipation—Doxorubicin—sarcoma	0.000245	0.00111	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Epirubicin—sarcoma	0.000245	0.00111	CcSEcCtD
Pentosan Polysulfate—Feeling abnormal—Doxorubicin—sarcoma	0.000236	0.00107	CcSEcCtD
Pentosan Polysulfate—Gastrointestinal pain—Doxorubicin—sarcoma	0.000235	0.00106	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Epirubicin—sarcoma	0.000228	0.00103	CcSEcCtD
Pentosan Polysulfate—Urticaria—Doxorubicin—sarcoma	0.000228	0.00103	CcSEcCtD
Pentosan Polysulfate—Abdominal pain—Doxorubicin—sarcoma	0.000227	0.00103	CcSEcCtD
Pentosan Polysulfate—Pruritus—Epirubicin—sarcoma	0.000219	0.000994	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Epirubicin—sarcoma	0.000212	0.000961	CcSEcCtD
Pentosan Polysulfate—Hypersensitivity—Doxorubicin—sarcoma	0.000211	0.000957	CcSEcCtD
Pentosan Polysulfate—Dizziness—Epirubicin—sarcoma	0.000205	0.000929	CcSEcCtD
Pentosan Polysulfate—Pruritus—Doxorubicin—sarcoma	0.000203	0.000919	CcSEcCtD
Pentosan Polysulfate—Vomiting—Epirubicin—sarcoma	0.000197	0.000893	CcSEcCtD
Pentosan Polysulfate—Diarrhoea—Doxorubicin—sarcoma	0.000196	0.000889	CcSEcCtD
Pentosan Polysulfate—Rash—Epirubicin—sarcoma	0.000195	0.000886	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Epirubicin—sarcoma	0.000195	0.000885	CcSEcCtD
Pentosan Polysulfate—Headache—Epirubicin—sarcoma	0.000194	0.00088	CcSEcCtD
Pentosan Polysulfate—Dizziness—Doxorubicin—sarcoma	0.00019	0.000859	CcSEcCtD
Pentosan Polysulfate—Nausea—Epirubicin—sarcoma	0.000184	0.000834	CcSEcCtD
Pentosan Polysulfate—Vomiting—Doxorubicin—sarcoma	0.000182	0.000826	CcSEcCtD
Pentosan Polysulfate—Rash—Doxorubicin—sarcoma	0.000181	0.000819	CcSEcCtD
Pentosan Polysulfate—Dermatitis—Doxorubicin—sarcoma	0.000181	0.000819	CcSEcCtD
Pentosan Polysulfate—Headache—Doxorubicin—sarcoma	0.00018	0.000814	CcSEcCtD
Pentosan Polysulfate—Nausea—Doxorubicin—sarcoma	0.00017	0.000772	CcSEcCtD
Pentosan Polysulfate—FGF1—Signaling by EGFR—HRAS—sarcoma	0.000153	0.000303	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PTPRC—sarcoma	0.000153	0.000303	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PLCG1—sarcoma	0.000152	0.000302	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000152	0.000301	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signal transduction—HRAS—sarcoma	0.000152	0.000301	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—PDGFRA—sarcoma	0.000152	0.0003	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by EGFR in Cancer—HRAS—sarcoma	0.000152	0.0003	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR—HRAS—sarcoma	0.000151	0.000299	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by PDGF—HRAS—sarcoma	0.000151	0.000299	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by ERBB2—HRAS—sarcoma	0.000151	0.000298	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—JUN—sarcoma	0.00015	0.000296	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 signaling—HRAS—sarcoma	0.00015	0.000296	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PLCG1—sarcoma	0.00015	0.000296	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—SRC—sarcoma	0.00015	0.000296	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—CTNNB1—sarcoma	0.000149	0.000294	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—ENO2—sarcoma	0.000148	0.000294	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—HRAS—sarcoma	0.000148	0.000292	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—KRAS—sarcoma	0.000147	0.00029	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CXCR4—sarcoma	0.000146	0.00029	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TLE1—sarcoma	0.000146	0.000289	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—ATF1—sarcoma	0.000145	0.000287	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—NRAS—sarcoma	0.000144	0.000285	CbGpPWpGaD
Pentosan Polysulfate—FGF1—B Cell Activation—HRAS—sarcoma	0.000143	0.000283	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—ATF1—sarcoma	0.000142	0.000281	CbGpPWpGaD
Pentosan Polysulfate—FGF2—DAP12 interactions—HRAS—sarcoma	0.000141	0.000279	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Fc epsilon receptor (FCERI) signaling—HRAS—sarcoma	0.000141	0.000279	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by FGFR in disease—HRAS—sarcoma	0.000141	0.000279	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR—HRAS—sarcoma	0.00014	0.000276	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PTPRC—sarcoma	0.000139	0.000276	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—KIT—sarcoma	0.000139	0.000275	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000139	0.000274	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by EGFR in Cancer—HRAS—sarcoma	0.000138	0.000274	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PLCG1—sarcoma	0.000138	0.000273	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by PDGF—HRAS—sarcoma	0.000138	0.000273	CbGpPWpGaD
Pentosan Polysulfate—FGF1—NGF signalling via TRKA from the plasma membrane—HRAS—sarcoma	0.000137	0.000271	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—CREB1—sarcoma	0.000137	0.00027	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PLCG1—sarcoma	0.000136	0.00027	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—SRC—sarcoma	0.000136	0.00027	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—SRC—sarcoma	0.000134	0.000266	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KIT—sarcoma	0.000133	0.000264	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TLE1—sarcoma	0.000133	0.000263	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CXCR4—sarcoma	0.000133	0.000263	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CREB1—sarcoma	0.000132	0.000262	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—NRAS—sarcoma	0.000131	0.00026	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—EGFR—sarcoma	0.000131	0.000259	CbGpPWpGaD
Pentosan Polysulfate—FGF2—B Cell Activation—HRAS—sarcoma	0.00013	0.000258	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—ATF1—sarcoma	0.00013	0.000257	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—NRAS—sarcoma	0.000129	0.000256	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—SRC—sarcoma	0.000129	0.000255	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—KIT—sarcoma	0.000127	0.000252	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—MMP2—sarcoma	0.000127	0.000251	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—CREB1—sarcoma	0.000127	0.000251	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—KIT—sarcoma	0.000127	0.000251	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PLCG1—sarcoma	0.000126	0.000249	CbGpPWpGaD
Pentosan Polysulfate—FGF2—NGF signalling via TRKA from the plasma membrane—HRAS—sarcoma	0.000125	0.000247	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—NRAS—sarcoma	0.000124	0.000246	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—KRAS—sarcoma	0.000124	0.000245	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFC—sarcoma	0.000123	0.000244	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KIT—sarcoma	0.000122	0.000241	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CREB1—sarcoma	0.000121	0.00024	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CXCR4—sarcoma	0.000121	0.00024	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CREB1—sarcoma	0.000121	0.000239	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—EGFR—sarcoma	0.00012	0.000237	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—EGFR—sarcoma	0.000118	0.000233	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—KIT—sarcoma	0.000118	0.000233	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—CREB1—sarcoma	0.000116	0.000229	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IGF1R—sarcoma	0.000114	0.000225	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—EGFR—sarcoma	0.000113	0.000224	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—KRAS—sarcoma	0.000113	0.000223	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFC—sarcoma	0.000112	0.000222	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CREB1—sarcoma	0.000112	0.000222	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—KRAS—sarcoma	0.000111	0.00022	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—MDM2—sarcoma	0.000109	0.000216	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—FOXO1—sarcoma	0.000108	0.000214	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PDGFRB—sarcoma	0.000108	0.000214	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—KRAS—sarcoma	0.000107	0.000211	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—PDGFRA—sarcoma	0.000106	0.00021	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—FOXO1—sarcoma	0.000106	0.00021	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PDGFRB—sarcoma	0.000106	0.00021	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling by NGF—HRAS—sarcoma	0.000105	0.000208	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—MDM2—sarcoma	0.000105	0.000208	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—PDGFRA—sarcoma	0.000104	0.000206	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—MDM2—sarcoma	0.0001	0.000199	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—MDM2—sarcoma	9.98e-05	0.000197	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FLT1—sarcoma	9.84e-05	0.000195	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—FOXO1—sarcoma	9.8e-05	0.000194	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PDGFRB—sarcoma	9.79e-05	0.000194	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—CTNNB1—sarcoma	9.74e-05	0.000193	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—FOXO1—sarcoma	9.68e-05	0.000192	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PLCG1—sarcoma	9.68e-05	0.000191	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PDGFRB—sarcoma	9.67e-05	0.000191	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—PDGFRA—sarcoma	9.63e-05	0.000191	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling by NGF—HRAS—sarcoma	9.6e-05	0.00019	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—MDM2—sarcoma	9.58e-05	0.00019	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—PDGFRA—sarcoma	9.52e-05	0.000188	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—JUN—sarcoma	9.51e-05	0.000188	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Innate Immune System—HRAS—sarcoma	9.46e-05	0.000187	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—CTNNB1—sarcoma	9.44e-05	0.000187	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CXCR4—sarcoma	9.3e-05	0.000184	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MDM2—sarcoma	9.27e-05	0.000183	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—ATF1—sarcoma	9.19e-05	0.000182	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Adaptive Immune System—HRAS—sarcoma	9.08e-05	0.00018	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FLT1—sarcoma	8.98e-05	0.000178	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—IL2—sarcoma	8.97e-05	0.000177	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KDR—sarcoma	8.95e-05	0.000177	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—FOXO1—sarcoma	8.94e-05	0.000177	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PDGFRB—sarcoma	8.92e-05	0.000177	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PLCG1—sarcoma	8.82e-05	0.000175	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—SRC—sarcoma	8.81e-05	0.000174	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—PDGFRA—sarcoma	8.79e-05	0.000174	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—JUN—sarcoma	8.73e-05	0.000173	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—JUN—sarcoma	8.67e-05	0.000172	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—CTNNB1—sarcoma	8.66e-05	0.000171	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—CTNNB1—sarcoma	8.61e-05	0.00017	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—VEGFA—sarcoma	8.58e-05	0.00017	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—SRC—sarcoma	8.53e-05	0.000169	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CXCR4—sarcoma	8.48e-05	0.000168	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—NRAS—sarcoma	8.47e-05	0.000168	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—ATF1—sarcoma	8.38e-05	0.000166	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KIT—sarcoma	8.24e-05	0.000163	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—NRAS—sarcoma	8.21e-05	0.000162	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—SRC—sarcoma	8.19e-05	0.000162	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KIT—sarcoma	8.09e-05	0.00016	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—CTNNB1—sarcoma	7.99e-05	0.000158	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—NRAS—sarcoma	7.88e-05	0.000156	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CREB1—sarcoma	7.84e-05	0.000155	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—SRC—sarcoma	7.83e-05	0.000155	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—SRC—sarcoma	7.78e-05	0.000154	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—EGFR—sarcoma	7.72e-05	0.000153	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CREB1—sarcoma	7.7e-05	0.000152	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—NRAS—sarcoma	7.53e-05	0.000149	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—NRAS—sarcoma	7.48e-05	0.000148	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—EGFR—sarcoma	7.48e-05	0.000148	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KIT—sarcoma	7.47e-05	0.000148	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—SRC—sarcoma	7.47e-05	0.000148	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KIT—sarcoma	7.38e-05	0.000146	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—KRAS—sarcoma	7.29e-05	0.000144	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—SRC—sarcoma	7.23e-05	0.000143	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IGF1R—sarcoma	7.21e-05	0.000143	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—NRAS—sarcoma	7.19e-05	0.000142	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—EGFR—sarcoma	7.18e-05	0.000142	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CREB1—sarcoma	7.11e-05	0.000141	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—KRAS—sarcoma	7.06e-05	0.00014	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CREB1—sarcoma	7.02e-05	0.000139	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—NRAS—sarcoma	6.95e-05	0.000138	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—FOXO1—sarcoma	6.87e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—EGFR—sarcoma	6.86e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PDGFRB—sarcoma	6.85e-05	0.000136	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—EGFR—sarcoma	6.82e-05	0.000135	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KIT—sarcoma	6.81e-05	0.000135	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—KRAS—sarcoma	6.78e-05	0.000134	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—PDGFRA—sarcoma	6.75e-05	0.000133	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IGF1R—sarcoma	6.58e-05	0.00013	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—EGFR—sarcoma	6.55e-05	0.00013	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MDM2—sarcoma	6.49e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CREB1—sarcoma	6.48e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—KRAS—sarcoma	6.48e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—MYC—sarcoma	6.48e-05	0.000128	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—KRAS—sarcoma	6.44e-05	0.000127	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—MDM2—sarcoma	6.37e-05	0.000126	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—EGFR—sarcoma	6.33e-05	0.000125	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—FOXO1—sarcoma	6.26e-05	0.000124	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PDGFRB—sarcoma	6.25e-05	0.000124	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Developmental Biology—HRAS—sarcoma	6.2e-05	0.000123	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—KRAS—sarcoma	6.18e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—PDGFRA—sarcoma	6.15e-05	0.000122	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Innate Immune System—HRAS—sarcoma	6e-05	0.000119	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—KRAS—sarcoma	5.98e-05	0.000118	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MDM2—sarcoma	5.88e-05	0.000116	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—MDM2—sarcoma	5.81e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—IL2—sarcoma	5.8e-05	0.000115	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Adaptive Immune System—HRAS—sarcoma	5.76e-05	0.000114	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—IL2—sarcoma	5.69e-05	0.000113	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KDR—sarcoma	5.68e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CCND1—sarcoma	5.65e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—JUN—sarcoma	5.64e-05	0.000112	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—CTNNB1—sarcoma	5.6e-05	0.000111	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—JUN—sarcoma	5.54e-05	0.00011	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Immune System—HRAS—sarcoma	5.51e-05	0.000109	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—CTNNB1—sarcoma	5.5e-05	0.000109	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Innate Immune System—HRAS—sarcoma	5.47e-05	0.000108	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MDM2—sarcoma	5.36e-05	0.000106	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Adaptive Immune System—HRAS—sarcoma	5.26e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KIT—sarcoma	5.23e-05	0.000104	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—IL2—sarcoma	5.19e-05	0.000103	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KDR—sarcoma	5.18e-05	0.000102	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Disease—HRAS—sarcoma	5.09e-05	0.000101	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—CTNNB1—sarcoma	5.07e-05	0.0001	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—SRC—sarcoma	5.06e-05	0.0001	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—JUN—sarcoma	5.05e-05	9.99e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—CTNNB1—sarcoma	5.01e-05	9.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CREB1—sarcoma	4.98e-05	9.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—SRC—sarcoma	4.97e-05	9.83e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—VEGFA—sarcoma	4.93e-05	9.75e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—NRAS—sarcoma	4.87e-05	9.63e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—NRAS—sarcoma	4.78e-05	9.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KIT—sarcoma	4.77e-05	9.44e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—CTNNB1—sarcoma	4.63e-05	9.16e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—SRC—sarcoma	4.59e-05	9.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CREB1—sarcoma	4.54e-05	8.98e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—MYC—sarcoma	4.53e-05	8.97e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—SRC—sarcoma	4.53e-05	8.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—EGFR—sarcoma	4.44e-05	8.78e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—NRAS—sarcoma	4.41e-05	8.73e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—NRAS—sarcoma	4.36e-05	8.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—EGFR—sarcoma	4.35e-05	8.62e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—KRAS—sarcoma	4.19e-05	8.29e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—SRC—sarcoma	4.18e-05	8.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MDM2—sarcoma	4.12e-05	8.15e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—KRAS—sarcoma	4.11e-05	8.14e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—MYC—sarcoma	4.11e-05	8.13e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—NRAS—sarcoma	4.02e-05	7.96e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—EGFR—sarcoma	4.02e-05	7.95e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—EGFR—sarcoma	3.97e-05	7.86e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—KRAS—sarcoma	3.8e-05	7.51e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MDM2—sarcoma	3.76e-05	7.43e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—KRAS—sarcoma	3.75e-05	7.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—MYC—sarcoma	3.75e-05	7.42e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—TP53—sarcoma	3.72e-05	7.37e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—IL2—sarcoma	3.68e-05	7.28e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—EGFR—sarcoma	3.67e-05	7.25e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CCND1—sarcoma	3.59e-05	7.1e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—JUN—sarcoma	3.58e-05	7.09e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF4—Signaling Pathways—HRAS—sarcoma	3.56e-05	7.05e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—CTNNB1—sarcoma	3.55e-05	7.03e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Immune System—HRAS—sarcoma	3.5e-05	6.92e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—KRAS—sarcoma	3.46e-05	6.85e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—IL2—sarcoma	3.36e-05	6.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CCND1—sarcoma	3.27e-05	6.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—JUN—sarcoma	3.27e-05	6.46e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—CTNNB1—sarcoma	3.24e-05	6.41e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Disease—HRAS—sarcoma	3.23e-05	6.39e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—SRC—sarcoma	3.21e-05	6.36e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Immune System—HRAS—sarcoma	3.19e-05	6.31e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—VEGFA—sarcoma	3.13e-05	6.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—NRAS—sarcoma	3.09e-05	6.11e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Disease—HRAS—sarcoma	2.94e-05	5.82e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—SRC—sarcoma	2.93e-05	5.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—MYC—sarcoma	2.88e-05	5.7e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—VEGFA—sarcoma	2.85e-05	5.64e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—NRAS—sarcoma	2.82e-05	5.58e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—EGFR—sarcoma	2.82e-05	5.57e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—KRAS—sarcoma	2.66e-05	5.26e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—MYC—sarcoma	2.62e-05	5.19e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—EGFR—sarcoma	2.57e-05	5.08e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—KRAS—sarcoma	2.43e-05	4.8e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—TP53—sarcoma	2.36e-05	4.68e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF1—Signaling Pathways—HRAS—sarcoma	2.26e-05	4.47e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—TP53—sarcoma	2.16e-05	4.27e-05	CbGpPWpGaD
Pentosan Polysulfate—FGF2—Signaling Pathways—HRAS—sarcoma	2.06e-05	4.08e-05	CbGpPWpGaD
